Welcome to our dedicated page for Procter & Gamble SEC filings (Ticker: PG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Procter & Gamble Company (PG) files a wide range of documents with the U.S. Securities and Exchange Commission, providing detailed insight into its operations, capital structure, governance, and shareholder policies. As a New York Stock Exchange‑listed issuer with common stock and multiple series of notes registered under Section 12(b) of the Exchange Act, P&G uses SEC filings to report material events, financing activities, executive and director matters, and shareholder meeting results.
Recent Form 8‑K filings illustrate the types of information investors can find. Regulation FD 8‑Ks document quarterly dividend declarations on common stock and ESOP convertible preferred stock, along with the company’s long record of consecutive dividend payments and increases. Other 8‑Ks report underwritten public offerings of U.S. dollar, euro, and pound sterling notes with various maturities, including floating rate notes and fixed‑rate notes issued under a shelf registration statement on Form S‑3, with related legal opinions filed as exhibits.
Additional 8‑Ks address governance topics such as the approval of The Procter & Gamble 2025 Stock and Incentive Compensation Plan, voting results from the Annual Meeting of Shareholders, and retirement announcements for senior executives. Earnings‑related 8‑Ks furnish quarterly results, slides used on earnings calls, and notices of webcasts. Together with the company’s proxy statement on Schedule 14A, these filings give a structured view of P&G’s executive compensation framework, board composition, and strategic priorities.
On this page, Stock Titan provides real‑time access to Procter & Gamble’s SEC filings as they appear on EDGAR, along with AI‑powered summaries to help explain the significance of each document. Users can quickly review annual and quarterly reports, current reports on Form 8‑K, and exhibits related to new debt offerings or compensation plans, as well as monitor items such as dividend announcements and shareholder vote outcomes without reading every page of the underlying filings.
Procter & Gamble (PG) director and CEO Jon R. Moeller reported a sale of 11,684 shares of Common Stock on 10/02/2025 at a reported price of $152.2317 per share to cover tax obligations from a Restricted Stock Unit award. After the sale, Mr. Moeller's direct beneficial ownership is reported as 319,932.232 shares. He also retains indirect holdings of 24,767.7039 shares through retirement plan trustees and 35,421.5707 shares attributed to his spouse, for combined reported beneficial ownership across direct and indirect holdings.
Balaji Purushothaman, Chief Human Resources Officer of Procter & Gamble (PG), reported a sale of 490 shares of common stock on 10/02/2025 at a price of $152.2317 per share to cover tax obligations related to a Restricted Stock Unit settlement. After the sale, the filing shows 12,616.0044 shares owned directly and an additional 5,166.0704 shares held indirectly via a retirement plan trustee, reflecting continued ownership after the transaction. The Form 4 was signed on 10/06/2025 by an attorney-in-fact for the reporting person.
Reporting person: Keith R. Alexandra, listed as an officer (CEO - Beauty). The filing discloses insider sales on 10/02/2025 of a total of 2,254 shares of Procter & Gamble Co (PG) to cover a tax obligation arising from settlement of a Restricted Stock Unit award. The reported sale price for each disposition was $152.2317. After the transactions the reporting person (directly and indirectly) held fractional share totals reported as 25,674.5056 (direct) and indirect interests via spouse and retirement plan trustee totaling additional fractional amounts. The form is signed by an attorney-in-fact on 10/06/2025.
Shailesh Jejurikar, Chief Operating Officer of Procter & Gamble Co (PG), reported a sale of 3,986 shares of common stock on 10/02/2025 at a price of $152.2317 per share. The filing states the shares were sold to cover tax obligations arising from the settlement of a Restricted Stock Unit award. After the transaction the reporting person shows 46,899.3817 shares directly beneficially owned and additional indirect holdings of 3,331.1419 shares (by a retirement plan trustee), 19,757 shares (Sankhya S Jejurikar Revocable Trust) and 17,849 shares (Shailesh Jejurikar Trust).
The Form 4 was signed by an attorney-in-fact on 10/06/2025. The filing is single-person (not a group) and lists the transaction code as S denoting a sale; the explanatory footnote confirms the sale was to cover taxes on RSU settlement.
Jennifer L. Davis, an officer (CEO - Health Care) of Procter & Gamble Co (PG), reported a sale of 3,227 shares of common stock on 10/02/2025. The shares were sold at a reported price of $152.2317 and were sold to cover a tax obligation upon settlement of a Restricted Stock Unit award. After the transaction, the filing shows 61,763.9326 shares held directly and 15,535.3029 shares held indirectly through a retirement plan trustee, for combined beneficial ownership disclosed on the form.
The sale is described as a routine disposition to satisfy taxes tied to equity compensation rather than an open-market divestiture for liquidity. The form is signed by an attorney-in-fact and reports the transaction under Section 16 rules for insiders.
Insider sale to cover taxes following RSU settlement: An officer of Procter & Gamble (PG) reported a disposition of 3,535 shares of common stock on 10/02/2025 at a price of $152.2317 per share. After the sale, the reporting person holds 34,816.145 shares directly and additionally reports indirect holdings of 481.8949 shares (retirement plan trustee) and 1,295.35 shares (international plans).
The filing states the shares were sold to cover tax obligations upon settlement of a Restricted Stock Unit award, and the Form 4 was signed by an attorney-in-fact on 10/06/2025. This is a routine, compliance-driven transaction that reduced direct beneficial ownership by a measurable amount.
Susan Street Whaley, Chief Legal Officer & Secretary of Procter & Gamble Co (PG), reported an insider sale on 10/02/2025. The filing shows 2,408 shares of common stock were sold at a price of $152.2317 per share to cover taxes on a prior restricted stock unit grant.
After the transaction, Ms. Whaley beneficially owned 31,769.8354 shares directly and an additional 6,531.6011 shares indirectly through a retirement plan trustee. The Form 4 was signed by an attorney-in-fact on 10/06/2025, and the filing indicates compliance with Section 16 reporting requirements.
Susan Street Whaley, Chief Legal Officer & Secretary of Procter & Gamble Co (PG), reported insider acquisitions on 10/01/2025. She acquired 5,742 shares through restricted stock units awarded under the company plan and recorded 26,531 stock option rights with an exercise/conversion price of $153.18, exercisable beginning 09/29/2028 and expiring 10/01/2035. After the transactions, Ms. Whaley beneficially owns 34,177.8354 shares directly and 6,531.6011 shares indirectly through a retirement plan trustee. The Form 4 was signed by an attorney-in-fact on 10/02/2025.
Raman Sundar G., listed as CEO-Fabric & Home Care at Procter & Gamble Co (PG), filed a Form 4 reporting transactions dated 10/01/2025. The filing shows a disposition of 41,886.4892 shares of common stock and an indirect beneficial ownership interest of 8,436.9135 shares held by a retirement plan trustee.
The filing also reports a derivative transaction dated 10/01/2025 labeled as an acquisition: a stock option with a $153.18 exercise/conversion price tied to 68,869 underlying common shares (listed as 68,869 shares beneficially owned following the transaction). An explanatory note states this reflects an adjustment to PST through September 30, 2025. The form is signed by an attorney-in-fact on 10/02/2025.
Gary A. Coombe, identified as CEO - Grooming and an officer of Procter & Gamble Co (PG), reported transactions on 10/01/2025. He was awarded 3,373 Restricted Stock Units under the 2019 Stock and Incentive Compensation Plan, increasing his direct beneficial ownership to 38,351.145 shares. The filing also shows indirect holdings of 481.8949 shares via a retirement plan trustee and 1,295.35 shares through an International Stock Ownership & Pension Plan (Switzerland). In derivatives, Mr. Coombe acquired 46,754 stock options with an exercise price of $153.18, exercisable beginning 09/29/2028 and expiring 10/01/2035. The form was signed by Wednesday Shipp as attorney-in-fact on 10/02/2025.